Stratial content of Ca2+-dependent regulator protein and dopaminergic receptor function (Q39207509)

10 September 2017

title

Stratial content of Ca2+-dependent regulator protein and dopaminergic receptor function (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

25 October 2022

1 reference

A. Lucchelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A28815

25 October 2022

A. Guidotti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A28815

25 October 2022

E. Costa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A28815

25 October 2022

language of work or name

English

0 references

publication date

1 October 1978

1 reference

10 September 2017

20 October 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=28815

full work available at URL

25 October 2022

https://api.elsevier.com/content/article/PII:000689937890313X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

https://api.elsevier.com/content/article/PII:000689937890313X?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

25 October 2022

1 reference

10 September 2017

volume

155

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

130-135

1 reference

Cyclic 3',5'-nucleotide phosphodiesterase. Demonstration of an activator

10 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Protein activator of cyclic 3′:5′-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase

25 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Regulation of dopamine receptor sensitivity by an endogenous protein activator or adenylate cyclase

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase

25 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Release of the phophodiesterase activator by cyclic AMP-dependent ATP:protein phosphotransferase from subcellular fractions of rat brain

25 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Ca++-dependent formation of brain adenylate cyclase-protein activator complex

25 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Turnover rates of γ-aminobutyric acid in substantia nigra, N. caudatus, globus pallidus and N. accumbens of rats injected with cataleptogenic and non-cataleptogenic antipsychotics

25 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Temporal changes in amine synthesizing enzymes of rat extrapyramidal structures after hemitransections or 6-hydroxydopamine administration

25 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Release of phosphodiesterase activator from particulate fractions of cerebellum and striatum by putative neurotransmitters

25 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine

25 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

25 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Regional effects of neuroleptics of dopamine metabolism and dopamine-sensitive adenylate cyclase activity

25 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Effect of single and repeated administration of haloperidol and sulpiride on striatal and retinal dopamine turnover in the rat

25 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

25 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Distribution of dopaminergic terminals in rat cerebral cortex: role of dopaminergic mesocortical system in ventral tegmental area syndrome

25 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs

25 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens

25 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(78)90313-X

25 October 2022

Identifiers

1 reference

10 September 2017

1 reference